Lars Fruergaard Jorgensen | President & Chief Executive Officer |
Karsten Munk Knudsen | Chief Financial Officer |
Camilla Sylvest | Executive Vice President, Head of Commercial Strategy & Corporate Affair |
Doug Langa | Executive Vice President & Head of North America Operations |
Martin Holst Lange | Executive Vice President & Head of Development |
Wimal Kapadia | Bernstein |
Peter Verdult | Citigroup |
Simon Baker | Redburn |
Michael Leuchten | UBS |
Emmanuel Papadakis | Deutsche Bank |
Steve Scala | Cowen |
Martin Parkhøi | Danske Bank |
Jo Walton | Crédit Suisse |
Kerry Holford | Berenberg |
Sachin Jain | Bank of America |
Richard Vosser | JPMorgan |
Welcome to the Q3 2021 Novo Nordisk A/S earnings conference call.
During the call, all participants will be in a listen-only mode, and afterwards, there will be a question-and-answer session. Today I'm pleased to present Lars Fruergaard Jorgensen, CEO. Please go ahead with your meeting.
Thank you very much.